Inhibitors of CK2 Kinase for the Treatment of Gliomas and Other Brain Tumors
Protein kinase CK2 has become a target of experimental antiglioma therapies as laboratory data are almost uniformly favorable and the number of synthetized CK2 inhibitors is rapidly growing. The evidence of their use for other brain tumors is on the increase as well. Great expectations are entrusted...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Polskie Towarzystwo Farmaceutyczne,
2024-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|